The 
Introduction
The neurodegenerative disorders fCJD, GerstmannStraussler-Scheinker syndrome and fatal familial insomnia (FFI) Tc-ECD revealed hypoperfusion in the right thalamus (Fig. 1a) .
t i n t h e b i l a t e r a l t h a l a mu s ( a r r o ws ) .

F i g u r e 2 . MRI a t 8 mo n t h s a f t e r d i s e a s e o n s e t ( Ma r c h 2 0 0 5 ) . Ax i a l DWI s h o ws h i g h -i n t e n s i t y a r e a s i n t h e r i g h t c a u -
In October, dysesthesia and ataxia progressed rapidly, and chorea of the left upper limb changed to ballism. In November, when involuntary movements developed in the bilateral extremities, SPECT revealed hypoperfusion in the bilateral thalamus (Fig. 1b) . 
Discussion
The present patient had ataxia, hemichorea, disturbance of both superficial and deep sensation, and spontaneous pain on the left side. These symptoms closely resemble the features of thalamic syndrome reported by Dejerine and Roussy (5). She also suffered from insomnia. A case of fCJD (E200 K) characterized clinically by insomnia and autonomic disturbance and neuropathologically by severe thalamic involvement has been reported by Chapman et al (2), and Taratuto et al (3) concluded that insomnia may be a prominent early symptom in cases of CJD linked to the E200K-129M haplotype in which the thalamus is severely affected. These findings suggested that the present patient had the thalamic form of fCJD (E200K).
The thalamic form of CJD, characterized by severe degeneration of the thalamus and inferior olivary nuclei, has been reported in some prion diseases including FFI (6) , the MM2-thalamic form of sCJD (2) , and fCJD (E200K) (3) . Sporadic CJD has been classified on the basis of the genotype at polymorphic codon 129 of the PrP and the physicochemical properties of the pathologic PrP; various classification systems have been proposed (7) (8) (9) (10) (11) . A simple classification for sCJD has been widely accepted, and now at least six phenotypes are recognized: MM1, MV1, VV1, MM2, MV2, and VV2 (9) . In the MM2 thalamic phenotype, the clinical features are insomnia and psychomotor hyperactivity in addition to ataxia and cognitive impairment (9) . This phenotype may be called sporadic fatal insomnia (SFI) because the clinical and pathologic features resemble those of FFI (12, 13) . In the MM2 thalamic form or SFI, lack of PSD on EEG, positivity or negativity for 14-3-3 protein in CSF, and normal findings of brain MRI have been reported (12, 13 This feature resembles those of previously reported patients with MM2 thalamic sCJD (9) or SFI (12, 13) .
In (Fig. 1b) . Mastrianni (14) and the MM2-thalamic form of sCJD (15) 
et al reported thalamic hypometabolism in SFI (13). Thalamic hypoperfusion or hypometabolism revealed by CBF-SPECT or [18F]2-fluoro-2-deoxy-D-glucose ([18F] FDG) and positron emission tomography (PET), which have been reported in FFI
